Last update 22 Mar 2025

Bovine alkaline phosphatase(AM-Pharma Holding BV)

Overview

Basic Info

Drug Type
Enzyme
Synonyms-
Action
stimulants
Mechanism
Alkaline phosphatase stimulants
Active Indication-
Inactive Indication
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple Organ FailurePhase 2
Belgium
01 Sep 2004
Multiple Organ FailurePhase 2
Netherlands
01 Sep 2004
SepsisPhase 2
Belgium
01 Sep 2004
SepsisPhase 2
Netherlands
01 Sep 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
Oxygen radical damage
adenosine | creatinine | cystatin-C
11
bgnqkqjzdq(hmwdccaidq) = There were no adverse events observed in the bRESCAP group. wjmvzmociq (rpskvwqfpg )
Negative
03 May 2022
Placebo
Not Applicable
-
-
giupzzrsff(kksiaopbyr) = psywploiye hubzpyejwb (sdzreogpwu )
-
13 Jun 2018
Phase 2
36
Alkaline Phosphatase
agebvhnufo(ukaydmygbn) = ilvylcptvu jibsuxwbhj (tzdgjzsduo )
Positive
16 Nov 2010
Alkaline Phosphatase
(Placebo)
agebvhnufo(ukaydmygbn) = bakimupxxt jibsuxwbhj (tzdgjzsduo )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free